Albany Molecular Research Inc (NASDAQ:AMRI)

19.77
Delayed Data
As of May 22
 +0.03 / +0.15%
Today’s Change
13.73
Today|||52-Week Range
23.95
+21.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues68.2M62.5M86.6M81.8M
 
 
 
 
 
Cost of Goods Sold40.8M48.3M57.5M58.1M
 
 
 
 
 
Depreciation And Amortization4.3M5.0M5.3M--
 
 
 
 
 
Operating ExpensesGross Income23.1M9.2M23.8M23.7M
 
 
 
 
 
General Expenses13.3M11.9M14.3M18.0M
 
 
 
 
 
Other Operating Expenses0.000.000.00382.0K
 
 
Research And Development128.0K568.0K229.0K490.0K
 
 
 
 
 
Total Operating Expenses58.3M65.2M77.1M76.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income9.8M-2.8M9.5M5.3M
 
 
 
 
 
Extraordinary Charge-5.2M-7.0M-6.6M-4.1M
 
 
 
 
 
Interest Expense On Debt2.7M2.6M2.7M3.0M
 
 
 
 
 
Other Expenses-192.0K235.0K-238.0K469.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.8M-12.1M-27.0K-1.3M
 
 
 
 
 
Income Taxes-1.9M-3.4M-1.8M-885.0K
 
 
 
 
 
Net Income3.7M-8.6M-1.9M-2.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS31.5M31.6M31.5M--
 
 
 
 
Shares To Calculate EPS Diluted32.6M31.6M31.5M--
 
 
 
 
 
Earnings Per ShareEPS$0.11-$0.27-$0.06-$0.07
 
 
 
 
 
EPS Diluted$0.11-$0.27-$0.06-$0.07
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account